A Tabulated Summary of Targeted and Biologic Therapies for Non–Small-Cell Lung Cancer
Update on HER1–3 in Advanced Non–Small-Cell Lung Cancer
Inhibition of MET Receptor Tyrosine Kinase and Its Ligand Hepatocyte Growth Factor
Targeting ALK, ROS1, and BRAF Kinases
Targeting MEK for the Treatment of Non–Small-Cell Lung Cancer
Phosphatidykinosital 3-Kinase and Mammalian Target of Rapamycin Pathway in Non–Small-Cell Lung Cancer
Phosphatidylinositol-3-Kinase Pathway
Targeting Fibroblast Growth Factor Receptor and Discoidin Domain Receptor 2 in Non–Small-Cell Lung Cancer
Miscellaneous Agents—Cytotoxics and Hormonal Agents
Miscellaneous Agents
PARP Inhibitors in Lung Cancer
Immune Therapies for Lung Cancer
Angiogenesis Inhibitors
Personalized Therapy
Histone Deacetylase Inhibitors in Non–Small-Cell Lung Cancer
Hsp90 Inhibitors
Doubling Down with Inhibitors of Notch and Hedgehog Signaling Pathways